Description

Neopax (imatinib) Coated Tablets 400 mg. №60

Ingredients

Active ingredient: Imatinib mesylate 400 mg.

Dosage

Recommended dosage: The usual dose is 400 mg daily. Dosage may vary based on individual patient needs.

Indications

Neopax (imatinib) coated tablets are indicated for the treatment of various types of cancers, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST).

Contraindications

Do not use Neopax (imatinib) coated tablets if you are allergic to imatinib or any other ingredients in the formulation. Consult your healthcare provider before use.

Directions

Take Neopax (imatinib) coated tablets as directed by your healthcare provider. Swallow the tablet whole with a full glass of water. Do not crush or chew the tablet.

Scientific Evidence

Imatinib has been extensively studied in clinical trials for its efficacy in treating various cancers. Research has shown that imatinib inhibits specific tyrosine kinase enzymes, which are involved in the growth of cancer cells.

Additional Information

Neopax (imatinib) coated tablets have revolutionized the treatment of certain types of cancers, offering patients a targeted therapy approach with fewer side effects compared to traditional chemotherapy.

It is important to follow your healthcare provider’s instructions carefully when taking Neopax (imatinib) coated tablets to ensure optimal treatment outcomes.